comprehensive -WSS

comprehensive

author：hotspot 2025-09-04 02:28:18 - browse：51558

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： What don’t we know about an Alzheimer’s drug side effect?

focus

WSS

Organ aging and disease risk measured by new blood test

Fetal surgery at risk from Dobbs and new abortion restrictions

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Despite FDA concern, risk that CAR

Timeline: Special counsel's probe into Trump's handling of classified documents

How to pay for weight loss drugs and save Medicare

hotspot

comprehensive

knowledge

Virginia high school admissions case could be legal follow

'The boss' wants server deleted: New allegations emerge in Trump indictment

Virginia high school admissions case could be legal follow

As the dark side of IVF slowly comes into focus, even more transparency is needed

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Ending health disparities requires full federal government, panel says

Drug repurposing or repositioning? The language matters

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Duchenne breakthrough therapy leaves behind pioneering families

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

leisure time

Behind warning on Apellis’s eye drug lies a conflict of interest

Biden to sign 'historic' executive order on how US military handles sexual assault cases

ReNAgade cuts staff seven months after raising $300 million

Takeda, Janssen join wearable maker to measure scratching

U.K. Biobank has 500,000 peoples' genome sequences available

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

hotspot

focus

knowledge

focus